NCT00425126View on ClinicalTrials.gov

Effect of Procrit (Epoetin Alfa) on Preventing Delayed Graft Function After Deceased Donor Renal Transplantation

PHASE4CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Delayed Graft Function
Interventions
DRUG

Epoetin Alfa

Trial Locations (1)

15212

Allegheny General Hospital, Pittsburgh

All Listed Sponsors
lead

West Penn Allegheny Health System

OTHER

NCT00425126 - Effect of Procrit (Epoetin Alfa) on Preventing Delayed Graft Function After Deceased Donor Renal Transplantation | Biotech Hunter | Biotech Hunter